Table 1.
Overview of baseline characteristics and parameters of the study patients.
| IgAN/HSPN in complete remission (defined as proteinuria < 0.03 g/mmol creatinine) |
IgAN/HSPN in partial remission (defined as proteinuria 0.03 to 0.11 g/mmol creatinine) |
Active IgAN/HSPN (defined as proteinuria > 0.11 g/mmol creatinine) |
P-value | |
|---|---|---|---|---|
| n | 67 | 51 | 42 | - |
| Age (years) | 37.9 ± 22.9 | 32.6 ± 17.3 | 40.3 ± 16.5 | 0.164 |
| Male (%) | 59.7 | 52.9 | 66.7 | 0.406 |
| eGFR (mL/min/1.73m2) | 84.2 ± 33.4 | 76.8 ± 30.1 | 59.0 ± 33.9 | 0.002 |
| Urinary IgA (mg/mmol creatinine) | 0.14 (0.08–0.25) | 0.44 (0.28–0.72) | 2.56 (1.37–3.79) | < 0.001 |
Results are expressed as %, mean ± SD or median (IQR). Abbreviations: IgAN, IgA nephropathy; HSPN, Henoch-Schönlein purpura nephritis; eGFR, estimated glomerular filtration rate.